A patient with a lesion not completely excised should be referred for SRS Incomplete excision is not an exclusion criterion; patients whose lesions are not completely excised may still be randomised into the trial to receive WBRT or observation.
Mortality, morbidity as well as incomplete excision rates are minimal.
Recurrence and possible malignant transformation are consequences of incomplete excision.
These lesions are benign with a very low incidence of recurrence even after incomplete excision.
Synchronous occult neoplastic involvement of the nipple may lead to incomplete excision of the tumor in patients undergoing breast conservation therapy, possibly leading to recurrence.
Genotoxic effects on lymphocytes in terms of strand breaks, alkali labile sites and incomplete excision repair were determined by the alkaline single cell microgel electrophoresis (Comet) assay.
High local recurrence rates are usually related to incomplete excision.
Local recurrence has been reported after incomplete excision as late as 10 years following removal, especially when the margins are irregular or inadequate.
The incomplete excision of the cystic tumor led us to re-operate 6 months after the first operation for the local disease recurrence.
Local control by radiotherapy is advisable in case of incomplete excision, as recurrence may transform into malignant melanoma (Rades et al. 2004).
Surgery remains the gold standard for clinical treatments of most tumors, but resection bears the potential risk of incomplete excision due to the invasiveness of the malignant tumor.
